Lin et al., 2001 - Google Patents
The metabotropic glutamate receptor system protects against ischemic free radical programed cell death in rat brain endothelial cellsLin et al., 2001
View HTML- Document ID
- 15672508286433589071
- Author
- Lin S
- Maiese K
- Publication year
- Publication venue
- Journal of Cerebral Blood Flow & Metabolism
External Links
Snippet
As one of the key determinants of ischemic injury, cerebrovascular endothelial cell (EC) degeneration may be dependent upon the generation of the free radical nitric oxide (NO) and the subsequent induction of programed cell death (PCD). Although the mechanisms that …
- 210000002889 Endothelial Cells 0 title abstract description 171
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lin et al. | The metabotropic glutamate receptor system protects against ischemic free radical programed cell death in rat brain endothelial cells | |
| Xu et al. | Amyloid β Peptide–Induced Cerebral Endothelial Cell Death Involves Mitochondrial Dysfunction and Caspase Activation | |
| Park et al. | Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain | |
| Zhao et al. | Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats | |
| Gill et al. | Role of caspase-3 activation in cerebral ischemia-induced neurodegeneration in adult and neonatal brain | |
| Sparaco et al. | Mitochondrial dysfunction and migraine: evidence and hypotheses | |
| Lin et al. | Prevention of nitric oxide-induced neuronal injury through the modulation of independent pathways of programmed cell death | |
| Sharma et al. | Modulation of celecoxib-and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil | |
| Yang et al. | Transient global cerebral ischemia induces a massive increase in protein sumoylation | |
| Nishimura et al. | Detrimental role of pericyte Nox4 in the acute phase of brain ischemia | |
| Digicaylioglu et al. | Acute neuroprotective synergy of erythropoietin and insulin-like growth factor I | |
| Yang et al. | Resveratrol treatment in different time-attenuated neuronal apoptosis after oxygen and glucose deprivation/reoxygenation via enhancing the activation of Nrf-2 signaling pathway in vitro | |
| Sabri et al. | Genetic elimination of eNOS reduces secondary complications of experimental subarachnoid hemorrhage | |
| Spagnuolo et al. | NF-κB protection against apoptosis induced by HEMA | |
| Haile et al. | Tissue-type plasminogen activator has a neuroprotective effect in the ischemic brain mediated by neuronal TNF-α | |
| Gandhi et al. | Hyperglycaemia and diabetes impair gap junctional communication among astrocytes | |
| Herve et al. | Cadasil | |
| Pallast et al. | Increased nuclear apoptosis-inducing factor after transient focal ischemia: a 12/15-lipoxygenase-dependent organelle damage pathway | |
| Zhang et al. | Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain | |
| Campbell et al. | High-fat feeding does not induce an autophagic or apoptotic phenotype in female rat skeletal muscle | |
| Abushik et al. | Pro-nociceptive migraine mediator CGRP provides neuroprotection of sensory, cortical and cerebellar neurons via multi-kinase signaling | |
| Ke et al. | Curcumin protects murine lung mesenchymal stem cells from H2O2 by modulating the Akt/Nrf2/HO-1 pathway | |
| Zhou et al. | Nitric oxide inhibits caspase activation and apoptotic morphology but does not rescue neuronal death | |
| Jeanneret et al. | Tissue-type plasminogen activator protects the postsynaptic density in the ischemic brain | |
| Pignataro et al. | Neuroprotection in ischemic mouse brain induced by stem cell-derived brain implants |